Press Releases

Aesthetic Medicine Market Size, Growth, Share | Industry Trends 2022-2030

The global aesthetic medicine market size is expected to be worth around US$ 130.7 billion by 2030, according to a new report by Vision Research Reports.

The global aesthetic medicine market size was valued at US$ 87.6 billion in 2020 and is anticipated to grow at a CAGR of 10.8% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38817

Report Coverage

Report Scope Details
Market Size US$ 130.7 Bn by 2030
Growth Rate CAGR of 10.8% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Procedure Type
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Allergan; Hologic (cynosure); Johnson & Johnson; Galderma; Lumenis; Solta Medical; Syneron Candela; Alma Laser

Growth Factors

According to the International Association for Physicians in Aesthetic Medicine (IAPAM), aesthetic medicine is ‘a branch of medicine focused on satisfying the aesthetic desires and goals of patient. The major aim of aesthetic medicine is to improve the physical appearance of the patient. Key drivers of the market include introduction of non-invasive medical devices for cosmetic procedures, growing focus on physical appearance, and rise in adoption among geriatric individuals.

By Procedure Type Analysis

The non-invasive procedures segment dominated the market for aesthetic medicine and accounted for the largest revenue share of 52.5% in 2020. The segment is expected to witness the fastest CAGR over the forecast period.

Invasive procedures such as liposuction, breast augmentation, nose reshaping, are some of the popular aesthetic procedures. Growing focus towards physical appearance has increased demand for these invasive procedures.

By Regional Analysis

North America accounted for the largest share of 36.0% in the market for aesthetic medicine. Advanced healthcare infrastructure, adoption of cosmetic procedures, increasing prevalence of skin disorders, and the presence of board certified and skilled cosmetic surgeons in the region are some of the major factors contributing to the growth of the aesthetic medicine market in this region.

In Asia Pacific, the market for aesthetic medicine is projected to witness the highest CAGR of 10.9% during the forecast period. The region is backed by countries such as China, India, and South Korea.

Key Players

  • Allergan
  • Hologic (cynosure)
  • Johnson & Johnson
  • Galderma
  • Lumenis
  • Solta Medical
  • Syneron Candela
  • Alma Laser

Market Segmentation

  • By Procedure Type
    • Invasive Procedures
      • Breast augmentation
      • Liposuction
      • Nose reshaping
      • Eyelid Surgery
      • Tummy tuck
      • Others
    • Non-invasive Procedures
      • Botox injections
      • Soft tissue fillers
      • Chemical peel
      • Laser hair removal
      • Microdermabrasion
      • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • India
      • Japan
      • China
      • Australia
      • New Zealand
    • Latin America
      • Brazil
      • Mexico
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38817

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Aesthetic Medicine Market, By Procedure Type

7.1.  Aesthetic Medicine Market, by Procedure Type, 2021-2030

7.1.1.    Invasive Procedures

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Non-invasive Procedures

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Aesthetic Medicine Market, Regional Estimates and Trend Forecast

8.1.  North America

8.1.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

8.1.2.    U.S.

8.1.3.    Rest of North America

8.1.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.2.  Europe

8.2.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

8.2.2.    UK

8.2.2.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.2.3.    France

8.2.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.2.4.    Rest of Europe

8.2.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.3.  APAC

8.3.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

8.3.2.    India

8.3.2.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.3.3.    China

8.3.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.3.4.    Japan

8.3.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.3.5.    Rest of APAC

8.3.5.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.4.  MEA

8.4.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

8.4.2.    GCC

8.4.2.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.4.3.    North Africa

8.4.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.4.4.    South Africa

8.4.4.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.4.5.    Rest of MEA

8.4.5.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.5.  Latin America

8.5.1.    Market Revenue and Forecast, by Procedure Type (2017-2030)

8.5.2.    Brazil

8.5.2.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

8.5.3.    Rest of LATAM

8.5.3.1.        Market Revenue and Forecast, by Procedure Type (2017-2030)

Chapter 9.    Company Profiles

9.1.  Allergan

9.1.1.    Company Overview

9.1.2.    Product Offerings

9.1.3.    Financial Performance

9.1.4.    Recent Initiatives

9.2.  Hologic (cynosure)

9.2.1.    Company Overview

9.2.2.    Product Offerings

9.2.3.    Financial Performance

9.2.4.    Recent Initiatives

9.3.  Johnson & Johnson

9.3.1.    Company Overview

9.3.2.    Product Offerings

9.3.3.    Financial Performance

9.3.4.    Recent Initiatives

9.4.  Galderma

9.4.1.    Company Overview

9.4.2.    Product Offerings

9.4.3.    Financial Performance

9.4.4.    Recent Initiatives

9.5.  Lumenis

9.5.1.    Company Overview

9.5.2.    Product Offerings

9.5.3.    Financial Performance

9.5.4.    Recent Initiatives

9.6.  Solta Medical

9.6.1.    Company Overview

9.6.2.    Product Offerings

9.6.3.    Financial Performance

9.6.4.    Recent Initiatives

9.7.  Syneron Candela

9.7.1.    Company Overview

9.7.2.    Product Offerings

9.7.3.    Financial Performance

9.7.4.    Recent Initiatives

9.8.  Alma Laser

9.8.1.    Company Overview

9.8.2.    Product Offerings

9.8.3.    Financial Performance

9.8.4.    Recent Initiatives

Chapter 10.  Research Methodology

10.1.              Primary Research

10.2.              Secondary Research

10.3.              Assumptions

Chapter 11.  Appendix

11.1.              About Us

11.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38817

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Show More

Related Articles

Back to top button